GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Blue Sail Medical Co Ltd (SZSE:002382) » Definitions » YoY EBITDA Growth

Blueil Medical Co (SZSE:002382) YoY EBITDA Growth : 11.11% (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Blueil Medical Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Blueil Medical Co's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 11.11%.

Blueil Medical Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥-0.05.


Blueil Medical Co YoY EBITDA Growth Historical Data

The historical data trend for Blueil Medical Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Blueil Medical Co YoY EBITDA Growth Chart

Blueil Medical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.29 161.29 -27.61 -87.77 -60.66

Blueil Medical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -350.00 -32.43 -406.67 14.09 11.11

Blueil Medical Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Blueil Medical Co's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(0.083-0.211)/ | 0.211 |
=-60.66 %

Blueil Medical Co's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (Q: Mar. 2024 )
=(EBITDA per Share (Q: Mar. 2024 )-EBITDA per Share (Q: Mar. 2023 )) / | EBITDA per Share (Q: Mar. 2023 )) |
=(-0.048--0.054)/ | -0.054 |
=11.11 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Blueil Medical Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Blueil Medical Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Blueil Medical Co (SZSE:002382) Business Description

Traded in Other Exchanges
N/A
Address
No. 21, Qingtian Road, Qilu Chemical Industrial Zone, Shandong, Zibo, CHN, 255400
Blue Sail Medical Co Ltd is engaged in the manufacturing of health protective gloves. The products of the company include single use PVC inspection gloves, disposable PVC oral examination, single use rubber inspection gloves, and disposable rubber oral examination.
Executives
Liu Wen Jing Director
Zhong Shu Qiao Directors, executives
Yu Su Hua Director
Li Zhen Ping Director
Sun Chuan Zhi Directors, executives
Gu Lei Min Executives
Li Bing Rong Executives, directors
Yang Fan Executives
Han Bang You Secretary, Director
Zhao Min Securities Affairs Representative
Zhang Yong Chen Executives
Cao Yuan He Executives

Blueil Medical Co (SZSE:002382) Headlines

No Headlines